echoloc

Indero (formerly Innovaderm) Tech Stack

Contract Research Organization for dermatology and rheumatology clinical trials

Research Services Montreal, Quebec 201–500 employees Founded 2000 Self-Owned

Indero operates a dual-focus CRO built around dermatology and rheumatology Phase I–IV trials, leveraging 25+ years of domain expertise. The tech stack—Medidata Rave, Veeva CDMS, SAS, Azure infrastructure—reflects standard pharma clinical ops, but the active hiring mix (56 research roles against 8 legal, 8 ops, 4 regulatory) and current project list (site activation, global Phase III, CDISC/SDTM validation) signal aggressive capacity scaling across trial execution rather than platform innovation.

Tech Stack 26 technologies

Core StackAzure AD Power Automate Power Platform SQL Server Power BI .NET SAS Salesforce Azure Microsoft Defender Sentinel Azure Key Vault Azure Policy Infor FSM Medidata Rave Exchange Online OneDrive DLP eSignature Azure SQL SOAR Pubmed Veeva CDMS CDISC CDISC SDTM Copilot Studio

What Indero (formerly Innovaderm) Is Building

Challenges

  • Site activation delays
  • Ensuring data quality and integrity
  • Increasing efficiency of statistical programming
  • Compliance with industry standards
  • Managing recruitment timelines
  • Managing risk in complex indications
  • Budget and change order management
  • Risk mitigation throughout clinical trials
  • Patient recruitment slow
  • Recruiting niche positions

Active Projects

  • Site activation
  • Global phase iii clinical trial
  • Clinical monitoring plan development
  • Design hybrid solutions integrating azure with on-premises infrastructure
  • Implementing risk-based monitoring strategies
  • Investigator’s meeting planning
  • Ract tool development
  • Validation of sdtm define.xml and adam define.xml
  • Internal initiatives to increase efficiency of statistical programming
  • Ecrf design and development

Hiring Activity

Accelerating100 roles · 90 in 30d

Department

Research
56
Legal
8
Ops
8
Data
6
HR
4
Regulatory
4
Security
4
Engineering
3

Seniority

Senior
41
Mid
40
Junior
12
Lead
2
Manager
2
Director
1
Other
1
Company intelligence

Find more companies like Indero (formerly Innovaderm) by tech stack, pain points and active projects

Get started free

About Indero (formerly Innovaderm)

Indero is a Montreal-based Contract Research Organization specializing in dermatology and rheumatology clinical development. Founded in 2000, the company operates across 201–500 employees with a service offering spanning study design, regulatory consulting, site selection, patient recruitment, clinical monitoring, pharmacovigilance, data management, biostatistics, and medical writing. The organization delivers Phase I through IV trials and maintains clinical research sites. Hiring activity is concentrated across Canada, the United States, and nine additional countries (Poland, Brazil, Spain, Romania, Germany, India, Argentina); the accelerating recruitment velocity indicates expansion of trial delivery capacity.

HeadquartersMontreal, Quebec
Company Size201–500 employees
Founded2000
Hiring MarketsCanada, United States, Poland, Brazil, Spain, Romania, Germany, India

Frequently Asked Questions

What clinical trial phases does Indero conduct?

Indero conducts Phase I, II, III, and IV clinical trials, with current projects including global Phase III programs. The company serves as both a full-service CRO and operates clinical research sites.

What data management tools does Indero use?

Indero's stack includes Medidata Rave for clinical trial management, Veeva CDMS for data management, SAS for biostatistics, and CDISC standards (SDTM, ADaM) for data validation and exchange.

How this profile is built

Indero (formerly Innovaderm)'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.